The IMPACT Trial: Single Inhaler Triple Therapy Fluticasone Furoate/Umeclidinium/Vilanterol Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients with COPD. Results on Cardiovascular Safety

Research output: Contribution to journalConference abstract in journalResearchpeer-review

  • D. A. Lipson
  • G. Criner
  • M. T. Dransfield
  • D. M. G. Halpin
  • M. K. Han
  • C. E. Jones
  • S. Kilbride
  • Lange, Peter
  • D. A. Lomas
  • F. J. Martinez
  • S. Pascoe
  • D. Singh
  • R. A. Wise
Original languageEnglish
Article numberB45
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume199
Issue numberA3334
ISSN1073-449X
Publication statusPublished - 2019

ID: 218435920